awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38241095-9F39E191-8804-4043-93CE-DF83D992C7D7
Q38241095-9F39E191-8804-4043-93CE-DF83D992C7D7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38241095-9F39E191-8804-4043-93CE-DF83D992C7D7
No clear evidence of a clinical benefit of a sequential therapy regimen with abiraterone acetate and enzalutamide.
P304
Q38241095-9F39E191-8804-4043-93CE-DF83D992C7D7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38241095-9F39E191-8804-4043-93CE-DF83D992C7D7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
359b07a88493a282e1becc501054c4cc929fce55
P304
1135-1140
http://www.w3.org/2001/XMLSchema#string